Clinical trial Recruiting at 14 sites Phase 3 Interventional Women only

Using azithromycin to prevent infections after cesarean delivery

Official title: Azithromycin Prophylaxis for Prelabor Cesarean Delivery Trial

Run by The George Washington University Biostatistics Center · NCT06605118 · Data updated 2026-11-12

This study is testing if giving azithromycin along with standard antibiotics can help prevent infections after cesarean deliveries for women and their babies.

Quick facts

PhasePhase 3
Study typeInterventional
SexWomen only
Enrollment8000 (estimated)
SponsorThe George Washington University Biostatistics Center
Academic / other
Locations14 sites (Birmingham, Alabama and 13 other locations)
StatusRecruiting
StartedNovember 6, 2024
Main results expectedNovember 30, 2027
Study endsNovember 30, 2027
Registry record updatedApril 9, 2026
Trial IDNCT06605118 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant individuals at or beyond 23 weeks' gestation scheduled for a cesarean delivery.

Probably not a fit

Patients with allergies to azithromycin, active infections requiring treatment, or those in labor prior to the cesarean will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase-III multi-center double-blind randomized controlled trial involves 8,000 individuals undergoing scheduled or prelabor cesarean deliveries. Participants will be randomized to receive either adjunctive azithromycin prophylaxis or a placebo, in addition to standard preoperative antibiotics. The primary goal is to determine if azithromycin reduces the risk of post-cesarean infections compared to placebo, while secondary objectives include assessing safety and resource use outcomes. Maternal and neonatal outcomes will be monitored up to six weeks postpartum.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of infections following cesarean deliveries, improving maternal health outcomes.

How similar studies have gone: Previous studies have shown promising results with antibiotic prophylaxis in surgical settings, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥ 23 weeks' gestation (ACOG dating criteria)
* Scheduled or prelabor cesarean delivery
* Singleton or twin gestation

Exclusion Criteria:

* Allergy or contraindication to azithromycin or macrolide antibiotics, including those with a history of cholestatic jaundice/hepatic dysfunction associated with prior use of azithromycin
* Chorioamnionitis
* Bacterial infection (e.g., pyelonephritis) requiring ongoing antibiotic treatment after delivery
* Premature rupture of membranes (PROM) or labor (i.e., contractions with ongoing cervical change)
* Fetal demise or known major congenital anomaly
* Azithromycin treatment within 7 days
* Planned use of antimicrobial prophylaxis after delivery for any reason
* Known structural heart disease or active cardiomyopathy (current ejection fraction\<40%)
* Known arrhythmia with QT prolongation or taking scheduled medications known to prolong the QT interval such that it would preclude the use of azithromycin
* Refusal or unable to obtain consent (e.g., language barrier)
* Participating in another intervention study that influences the primary outcome in this study
* Participation in this trial in a previous pregnancy. Patients who were screened in a previous pregnancy, but not randomized, do not have to be excluded.

Where it's running

  • University of Alabama - Birmingham
    Birmingham, Alabama, United States
    Recruiting
  • Regents of the University of California San Francisco
    San Francisco, California, United States
    Recruiting
  • Northwestern University
    Chicago, Illinois, United States
    Recruiting
  • Columbia University
    New York, New York, United States
    Recruiting
  • University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina, United States
    Recruiting
  • Duke University
    Durham, North Carolina, United States
    Recruiting
Show 8 more locations
  • Case Western Reserve University
    Cleveland, Ohio, United States
    Recruiting
  • Ohio State University
    Columbus, Ohio, United States
    Recruiting
  • Hospital of the University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Magee Women's Hospital
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Brown Univeristy
    Providence, Rhode Island, United States
    Recruiting
  • Baylor College of Medicine
    Houston, Texas, United States
    Recruiting
  • University of Texas - Houston
    Houston, Texas, United States
    Recruiting
  • University of Utah
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

  • Principal investigator: Rebecca G Clifton, PhD — The George Washington University Biostatistics Center
  • Study coordinator: Rebecca G Clifton, PhD
  • Email: rclifton@bsc.gwu.edu
  • Phone: 301-881-9260

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.